| Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 16 Jun 2020 | 6 Sep 2019 | 16 Jun 2020 |
| Utility: Method for preparing electrocompetent yeast cells, and method for using said cells Filling date: 9 Sep 2025 Issue date: 16 Jun 2020 | 15 Nov 2017 | 16 Jun 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Filling date: 9 Sep 2025 Issue date: 9 Jun 2020 | 24 Jan 2020 | 9 Jun 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 2 Jun 2020 | 23 Jan 2020 | 2 Jun 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 2 Jun 2020 | 21 Jan 2020 | 2 Jun 2020 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 9 Sep 2025 Issue date: 2 Jun 2020 | 5 Dec 2019 | 2 Jun 2020 |
| Utility: Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 2 Jun 2020 | 6 Sep 2019 | 2 Jun 2020 |
| Utility: Uterine cancer treatments Filling date: 9 Sep 2025 Issue date: 2 Jun 2020 | 8 Oct 2018 | 2 Jun 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 26 May 2020 | 13 Dec 2019 | 26 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 2 Oct 2019 | 19 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 5 Jul 2019 | 19 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 17 May 2019 | 19 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against CLL and other cancers Filling date: 9 Sep 2025 Issue date: 19 May 2020 | 17 May 2019 | 19 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 5 May 2020 | 30 Aug 2019 | 5 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 5 May 2020 | 30 Aug 2019 | 5 May 2020 |
| Utility: Immunotherapy against melanoma and other cancers Filling date: 9 Sep 2025 Issue date: 5 May 2020 | 16 Oct 2018 | 5 May 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against esophageal cancer and other cancers Filling date: 9 Sep 2025 Issue date: 21 Apr 2020 | 25 Sep 2019 | 21 Apr 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 21 Apr 2020 | 3 May 2019 | 21 Apr 2020 |
| Utility: Engineered T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 14 Apr 2020 | 5 Nov 2018 | 14 Apr 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy and methods for generating scaffolds for the use against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Apr 2020 | 21 May 2018 | 14 Apr 2020 |
| Utility: Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules Filling date: 9 Sep 2025 Issue date: 14 Apr 2020 | 5 Nov 2015 | 14 Apr 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC, SCLC and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 26 Sep 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 25 Sep 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 5 Jul 2019 | 24 Mar 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 24 May 2019 | 24 Mar 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 16 May 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 10 May 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 20 Mar 2019 | 24 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers Filling date: 9 Sep 2025 Issue date: 24 Mar 2020 | 31 Dec 2018 | 24 Mar 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 17 Mar 2020 | 29 Jun 2018 | 17 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 3 Mar 2020 | 6 Sep 2019 | 3 Mar 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 3 Mar 2020 | 23 Jul 2019 | 3 Mar 2020 |
| Utility: Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers Filling date: 9 Sep 2025 Issue date: 3 Mar 2020 | 17 May 2018 | 3 Mar 2020 |
| Utility: Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers Filling date: 9 Sep 2025 Issue date: 25 Feb 2020 | 4 Nov 2019 | 25 Feb 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 25 Feb 2020 | 30 Aug 2019 | 25 Feb 2020 |
| Utility: Immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (CLL) Filling date: 9 Sep 2025 Issue date: 25 Feb 2020 | 24 May 2019 | 25 Feb 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against pancreatic cancer and other cancers Filling date: 9 Sep 2025 Issue date: 18 Feb 2020 | 6 Sep 2019 | 18 Feb 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 4 Feb 2020 | 23 Jul 2019 | 4 Feb 2020 |
| Utility: Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers Filling date: 9 Sep 2025 Issue date: 4 Feb 2020 | 28 Mar 2019 | 4 Feb 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 4 Feb 2020 | 15 Aug 2017 | 4 Feb 2020 |
| Utility: Method for the absolute quantification of naturally processed HLA-restricted cancer peptides Filling date: 9 Sep 2025 Issue date: 28 Jan 2020 | 15 Dec 2015 | 28 Jan 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 21 Jan 2020 | 16 Mar 2017 | 21 Jan 2020 |
| Utility: Transfected T-cells and T-cell receptors for use in immunotherapy against cancers Filling date: 9 Sep 2025 Issue date: 21 Jan 2020 | 16 Mar 2017 | 21 Jan 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Jan 2020 | 10 Jul 2019 | 14 Jan 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers Filling date: 9 Sep 2025 Issue date: 14 Jan 2020 | 21 Feb 2019 | 14 Jan 2020 |
| Utility: Peptides and combinations of peptides for use in immunotherapy against lung cancer, including NSCLC and other cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 23 Jul 2019 | 7 Jan 2020 |
| Utility: Peptides and scaffolds for use in immunotherapy against head and neck squamous cell carcinoma and other cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 23 May 2019 | 7 Jan 2020 |
| Utility: Peptides and combination of peptides for use in immunotherapy against various cancers Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 10 May 2019 | 7 Jan 2020 |
| Utility: Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 29 Mar 2019 | 7 Jan 2020 |
| Utility: T cell receptors and immune therapy using the same Filling date: 9 Sep 2025 Issue date: 7 Jan 2020 | 13 Jul 2018 | 7 Jan 2020 |
